GeoVax Labs, Inc.
GOVX
$0.72
$0.000.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -84.76% | -37.06% | 8.52% | 1,942.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -84.76% | -37.06% | 8.52% | 1,942.93% |
| Cost of Revenue | -40.02% | -32.35% | -23.58% | 1.77% | 14.67% |
| Gross Profit | 20.58% | 16.97% | 20.89% | -0.69% | 12.20% |
| SG&A Expenses | -9.78% | 1.31% | 11.54% | 17.46% | 7.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.13% | -26.10% | -17.08% | 4.75% | 13.17% |
| Operating Income | 17.96% | 12.81% | 13.94% | -4.28% | 8.13% |
| Income Before Tax | 17.66% | 12.78% | 14.11% | -4.06% | 7.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.66% | 12.78% | 14.11% | -4.06% | 7.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.66% | 12.78% | 14.11% | -4.06% | 7.84% |
| EBIT | 17.96% | 12.81% | 13.94% | -4.28% | 8.13% |
| EBITDA | 17.91% | 12.74% | 13.89% | -4.39% | 8.17% |
| EPS Basic | 78.26% | 79.37% | 80.56% | 78.65% | 80.37% |
| Normalized Basic EPS | 78.26% | 79.37% | 80.56% | 78.65% | 80.37% |
| EPS Diluted | 78.26% | 79.37% | 80.56% | 78.65% | 80.37% |
| Normalized Diluted EPS | 78.26% | 79.37% | 80.56% | 78.65% | 80.37% |
| Average Basic Shares Outstanding | 425.72% | 323.02% | 334.03% | 330.68% | 400.90% |
| Average Diluted Shares Outstanding | 425.72% | 323.02% | 334.03% | 330.68% | 400.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |